YIH
EIGR

Y-Intercept (HK)’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Y-Intercept (HK)’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,374
Closed -$114K – 1751
2023
Q2 		$114K Buy
+5,374
New +$114K 0.01% 1058